{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:19:26Z","timestamp":1791422366239,"version":"4.3.3"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1080\/14653240410005375","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T01:07:03Z","timestamp":1104196023000},"page":"533-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia"],"prefix":"10.1016","volume":"6","author":[{"given":"G.","family":"Kobbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Steidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kondakci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Graef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aivado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vaupel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-N.","family":"Huenerlituerkoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kronenwett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Germing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1080\/14653240410005375_bib0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJM198009043031007","article-title":"Transplantation of marrow from an unrelated donor to a patient with acute leukemia","volume":"303","author":"Hansen","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1080\/14653240410005375_bib0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1702519","article-title":"Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience","volume":"26","author":"Sierra","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V81.2.543.543","article-title":"Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program","volume":"81","author":"McGlave","year":"1993","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0020","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V97.6.1572","article-title":"Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome","volume":"97","author":"Cornelissen","year":"2001","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0025","first-page":"3996","article-title":"T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/bbmt.2002.v8.abbmt080601","article-title":"Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation","volume":"8","author":"Alyea","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0035","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1080\/1042819021000033015","article-title":"188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia","volume":"43","author":"Bunjes","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1080\/14653240410005375_bib0040","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood.V91.8.3079.3079_3079_3083","article-title":"Risks of developing Epstein-Barr virusrelated lymphoproliferative disorders after T-cell-depleted marrow transplants CAMPATH Users","volume":"91","author":"Hale","year":"1998","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0045","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.1365-2141.2002.03731.x","article-title":"CD34+- enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte addback","volume":"118","author":"Bornhauser","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1080\/14653240410005375_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/146532401753174007","article-title":"The current status of T-cell depleted allogeneic stemcell transplants in adult patients with AML","volume":"3","author":"Bunjes","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240410005375_bib0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/bbmt.2002.v8.pm12171481","article-title":"Preemptive cellular immunotherapy after Tcell- depleted allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Baron","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0060","first-page":"1214","article-title":"Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions","volume":"95","author":"Porter","year":"2000","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0065","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/blood-2002-05-1615","volume":"101","author":"Elmaagacli","year":"2003","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00277-001-0384-9","article-title":"Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells","volume":"80","author":"Ottinger","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1080\/14653240410005375_bib0080","first-page":"449","article-title":"Selection of CD34- positive blood cells for allogeneic transplantation: approaches to optimize D34-cell recovery, purity, viability, and T-cell depletion","volume":"23","author":"Fritsch","year":"2000","journal-title":"Onkologie"},{"key":"10.1080\/14653240410005375_bib0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/146532401317248081","article-title":"CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts","volume":"3","author":"O\u2019Donnell","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240410005375_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0609.2003.02811.x","article-title":"Quantitative realtime reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation","volume":"70","author":"Neumann","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1080\/14653240410005375_bib0095","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1703094","article-title":"Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human\/mouse antiTNFalpha antibody","volume":"28","author":"Kobbe","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0105","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bmt.1703277","article-title":"Individually adjusted prophylactic donor lymphocyte infusions after CD34- selected allogeneic peripheral blood stem cell transplantation","volume":"28","author":"Ferra","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0110","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1182\/blood.V89.11.3967","article-title":"Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood","volume":"89","author":"Urbano-Ispizua","year":"1997","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.bmt.1701386","article-title":"Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish group of allo-PBT","volume":"22","author":"Urbano-Ispizua","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/14653240310003594","article-title":"Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD","volume":"5","author":"Roberts","year":"2003","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240410005375_bib0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/152581603322023043","article-title":"Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation","volume":"12","author":"Goerner","year":"2003","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1080\/14653240410005375_bib0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bmt.1701889","article-title":"Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts","volume":"24","author":"Behringer","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0135","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(00)02284-4","article-title":"T-cell reconstitution after stem-cell transplantation: by which organ","volume":"355","author":"Storek","year":"2000","journal-title":"Lancet"},{"key":"10.1080\/14653240410005375_bib0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1704235","article-title":"Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients","volume":"32","author":"Fallen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0145","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1182\/blood.V95.12.3990.012k40_3990_3995","article-title":"Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-celldepleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire","volume":"95","author":"Verfuerth","year":"2000","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.bmt.1702202","article-title":"Unrelated peripheral blood stem cell transplantation with \u2018megadoses\u2019 of purified CD34+ cells in three children with refractory severe aplastic anemia","volume":"25","author":"Schwinger","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1749-6632.1999.tb08478.x","article-title":"The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation","volume":"872","author":"Reisner","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1080\/14653240410005375_bib0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/146532401317070899","article-title":"Pharmacokinetics of CAMPATH-1H in BMT patients","volume":"3","author":"Rebello","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240410005375_bib0165","first-page":"29","article-title":"The pharmacokinetics of antithymocyte globulin (ATG) following intravenous infusion in man","volume":"45","author":"Bunn","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1080\/14653240410005375_bib0170","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood-2002-09-2687","article-title":"Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications","volume":"102","author":"Morris","year":"2003","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bmt.1703928","article-title":"Cyclosporine is required to prevent severe acute GVHD following T-celldepleted peripheral blood stem cell transplantation","volume":"31","author":"Solomon","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0180","first-page":"347","article-title":"The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation","volume":"30","author":"Pihusch","year":"2002","journal-title":"Bone MarrowTransplant"},{"key":"10.1080\/14653240410005375_bib0185","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood.V100.2.397","article-title":"Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose","volume":"100","author":"Guglielmi","year":"2002","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1080\/14653240410005375_bib0200","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood.V102.3.839","article-title":"Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation","volume":"102","author":"Chakrabarti","year":"2003","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0205","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/00007890-200110270-00024","article-title":"Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity","volume":"72","author":"Chakrabarti","year":"2001","journal-title":"Transplantation"},{"key":"10.1080\/14653240410005375_bib0210","first-page":"387","article-title":"In vivo\/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT","volume":"15","author":"Hertenstein","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bmt.1702752","article-title":"Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant","volume":"27","author":"Regn","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"10.1080\/14653240410005375_bib0220","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1007\/s00277-003-0772-4","article-title":"Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"82","author":"Einsele","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1080\/14653240410005375_bib0225","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1182\/blood.V99.12.4357","article-title":"High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution","volume":"99","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.bmt.1703847","article-title":"Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning","volume":"31","author":"Chakrabarti","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0235","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0240","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0301-472X(02)00785-3","article-title":"Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells","volume":"30","author":"Klangsinsirikul","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1080\/14653240410005375_bib0245","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood.V86.12.4422.bloodjournal86124422","article-title":"Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease","volume":"86","author":"Pan","year":"1995","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0250","first-page":"333","article-title":"Th1\/Th2 lymphokine profile of T cells present in the blood of granulocyte-colony stimulating factor-treated stemcell donors: up or down modulation","volume":"97","author":"Vasconcelos","year":"2001","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0255","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V95.8.2484","article-title":"Granulocyte-colony stimulating factor mobilizes T helper 2- inducing dendritic cells","volume":"95","author":"Arpinati","year":"2000","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0260","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V91.10.3671","article-title":"Toxicity and efficacy of defined doses of CD4(-) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant","volume":"91","author":"Alyea","year":"1998","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0265","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/bbmt.2002.v8.abbmt080625","article-title":"Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion","volume":"8","author":"Soiffer","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0270","first-page":"835","article-title":"Low incidence of acute graftversus- host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update","volume":"88","author":"Baron","year":"2003","journal-title":"Haematologica"},{"key":"10.1080\/14653240410005375_bib0275","first-page":"78","article-title":"Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation","volume":"87","author":"Baron","year":"2002","journal-title":"Haematologica"},{"key":"10.1080\/14653240410005375_bib0280","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/10428190290016827","article-title":"The role of donor age in naive T-cell recovery following allogeneic hematopoietic stem cell transplantation: the younger the better","volume":"43","author":"Azuma","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1080\/14653240410005375_bib0285","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","article-title":"Comparison of immune reconstitution after unrelated and related T-celldepleted bone marrow transplantation: effect of patient age and donor leukocyte infusions","volume":"93","author":"Small","year":"1999","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0290","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/00007890-200004150-00022","article-title":"Immune reconstitution after allogeneic bone marrow transplantation depleted of Tcells","volume":"69","author":"Davison","year":"2000","journal-title":"Transplantation"},{"key":"10.1080\/14653240410005375_bib0295","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek","year":"2001","journal-title":"Blood"},{"key":"10.1080\/14653240410005375_bib0300","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1703118","article-title":"Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen","volume":"28","author":"Morecki","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240410005375_bib0305","first-page":"2052","article-title":"Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor Tcells with cytolytic activity directed against recipient hematopoietic cells","volume":"8","author":"Zorn","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1080\/14653240410005375_bib0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324904707665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324904707665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:09:38Z","timestamp":1761430178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324904707665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1465324904707665"],"URL":"https:\/\/doi.org\/10.1080\/14653240410005375","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240410005375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}